SGLT-2 inhibitors reduce adverse CV events associated with restenosis in stents in patients with type 2 diabetes.

Long-Term Steroid Use Linked to Adrenal Insufficiency

Long-term use of systemic corticosteroids is linked to adrenal insufficiency and related hospitalisation, whereas long-term use of inhaled corticosteroids is modestly linked to adrenal insufficiency.

New Drug Shows Promise for Menopausal Hot Flushes and Sleep

Elinzanetant demonstrates superior or comparable efficacy to existing non-hormonal treatments in reducing the frequency of menopausal hot flushes while significantly improving sleep.

GLP-1s Prevent Death as a Result of Substance Use Disorders

New research shows reduction in addiction and deaths while using GLP-1s.

EyePoint Sues Rival Ocular Therapeutix, Alleging False Claims About Eye Drug

EyePoint filed a lawsuit on Friday accusing rival Ocular Therapeutix of spreading false or ⁠misleading information about EyePoint and its lead experimental eye...

Dementia, AD Risk Nearly Double in Advanced CKM Syndrome

Postmenopausal Bone Gains From Exercise May Plateau

Younger women and those with normal BMI who met certain thresholds for weekly moderate-intensity physical activity experienced improved lumbar spine health, according to an analysis of NHANES data.

Diabetes Drug Shortages: Where Things Stand and What to Know

While most shortages have eased, some important medications remain in short supply.

Brazilian 10-Year Diabetes Risk Calculator

A Brazilian calculator using up to 12 clinical and laboratory predictors estimates an individual’s 10 year diabetes risk and may better prioritize patients for prevention than FINDRISC.

Eye Condition Risk Elevated With Semaglutide, but Still Low

New VA database study is the latest to find a small but significant increased risk for nonarteritic anterior ischemic optic neuropathy.

Judge Says he Will Bar RFK Move Aimed At Cutting Gender-affirming Care for Minors

A U.S. judge on Thursday said he would block an effort by Health Secretary Robert F. Kennedy Jr that would have sharply restricted medical providers from ⁠providing gender...

Axitinib Ups Neuroendocrine Tumor Objective Response Rate

Patients were randomly assigned 1:1 to receive either axitinib 5 mg orally twice daily or matching placebo, both combined with octreotide long-acting release 30 mg, in an international study.

New Model May Improve Surgical Risk Prediction in Cirrhosis

A new European risk model may improve the prediction of postoperative mortality in patients with cirrhosis.

Frequent Insulin Infusion Site Failures ‘a Huge Problem’

Unexplained hyperglycemic events may be due to undetected occlusions, a common problem that experts say needs to be addressed through education and technology.

GLP-1s Tied to Lower Risk of Psychiatric Decline

A Swedish national cohort study shows some GLP-1s — semaglutide in particular — are associated with reduced risk of psychiatric decline in patients with depression or anxiety.

A1c or CGM Metrics: Which Should Be the Gold Standard?

Two experts debated the question at the recent Advanced Technologies and Treatments for Diabetes meeting.

Four-Drug Regimen Superior to Escalating Metformin in T2D

Adding a fourth oral antidiabetic drug to a triple regimen beats metformin dose escalation for achieving glycemic control.